SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-07-076195
Filing Date
2007-10-23
Accepted
2007-10-22 19:25:30
Documents
6
Period of Report
2007-10-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a07-27173_18k.htm 8-K 48773
2 EX-2.1 a07-27173_1ex2d1.htm EX-2.1 710931
3 EX-10.2 a07-27173_1ex10d2.htm EX-10.2 25631
4 EX-10.3 a07-27173_1ex10d3.htm EX-10.3 132598
5 EX-99.1 a07-27173_1ex99d1.htm EX-99.1 25478
6 GRAPHIC g271731mni001.jpg GRAPHIC 9552
  Complete submission text file 0001104659-07-076195.txt   958516
Mailing Address 119 FOURTH AVE NEEDHAM MA 021942725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
AVANT IMMUNOTHERAPEUTICS INC (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-15006 | Film No.: 071184062
SIC: 2835 In Vitro & In Vivo Diagnostic Substances